Senior staff fellow
US Food and Drug Administration
Dr. Jan-Shiang (Jesse) Taur is currently a senior staff fellow at Office of Bioequivalence, Office of Generic Drugs, U.S. Food and Drug administration (FDA). Dr. Taur is responsible in reviewing the bioequivalence portion of Abbreviated New Drug Application (ANDA), control correspondences and protocols of an Investigational New Drug Application (IND). Prior to FDA, Dr. Taur worked at Eisai Inc. for 10 years, where he focused on the DMPK aspect of drug candidates at different discovery/development stages.